Geode Capital Management’s Enveric Biosciences ENVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1K | Buy |
28,160
+1,602
| +6% | +$1.94K | ﹤0.01% | 4283 |
|
|
2025
Q1 | $36.9K | Sell |
26,558
-190,036
| -88% | -$264K | ﹤0.01% | 4244 |
|
|
2024
Q4 | $77.6K | Sell |
216,594
-1,299
| -0.6% | -$466 | ﹤0.01% | 4159 |
|
|
2024
Q3 | $103K | Buy |
217,893
+173,234
| +388% | +$82.1K | ﹤0.01% | 4093 |
|
|
2024
Q2 | $27.7K | Buy |
44,659
+31,541
| +240% | +$19.6K | ﹤0.01% | 4400 |
|
|
2024
Q1 | $13.1K | Hold |
13,118
| – | – | ﹤0.01% | 4529 |
|
|
2023
Q4 | $17.1K | Hold |
13,118
| – | – | ﹤0.01% | 4538 |
|
|
2023
Q3 | $30.3K | Buy |
+13,118
| New | +$30.3K | ﹤0.01% | 4534 |
|
|
2022
Q3 | – | Sell |
-204,569
| Closed | -$43K | – | 5032 |
|
|
2022
Q2 | $43K | Buy |
204,569
+38,032
| +23% | +$7.99K | ﹤0.01% | 4808 |
|
|
2022
Q1 | $54K | Hold |
166,537
| – | – | ﹤0.01% | 4789 |
|
|
2021
Q4 | $154K | Buy |
166,537
+51,275
| +44% | +$47.4K | ﹤0.01% | 4588 |
|
|
2021
Q3 | $238K | Buy |
115,262
+16,368
| +17% | +$33.8K | ﹤0.01% | 4366 |
|
|
2021
Q2 | $235K | Buy |
98,894
+35,800
| +57% | +$85.1K | ﹤0.01% | 4274 |
|
|
2021
Q1 | $193K | Buy |
+63,094
| New | +$193K | ﹤0.01% | 4120 |
|
|
2020
Q4 | – | Sell |
-10,788
| Closed | -$14K | – | 4276 |
|
|
2020
Q3 | $14K | Hold |
10,788
| – | – | ﹤0.01% | 4134 |
|
|
2020
Q2 | $16K | Hold |
10,788
| – | – | ﹤0.01% | 4078 |
|
|
2020
Q1 | $10K | Hold |
10,788
| – | – | ﹤0.01% | 4080 |
|
|
2019
Q4 | $24K | Sell |
10,788
-258,907
| -96% | -$576K | ﹤0.01% | 4140 |
|
|
2019
Q3 | $45K | Buy |
+269,695
| New | +$45K | ﹤0.01% | 4075 |
|